BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38270932)

  • 1. Why is early-onset atrial fibrillation uncommon in patients with Duchenne muscular dystrophy? Insights from the mdx mouse.
    Nguyen MN; Hooper C; Stefanini M; Vrellaku B; Carnicer R; Wood MJ; Simon JN; Casadei B
    Cardiovasc Res; 2024 Apr; 120(5):519-530. PubMed ID: 38270932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
    Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
    Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
    Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.
    Ramachandran J; Schneider JS; Crassous PA; Zheng R; Gonzalez JP; Xie LH; Beuve A; Fraidenraich D; Peluffo RD
    Biochem J; 2013 Jan; 449(1):133-42. PubMed ID: 23009292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
    Hiyoshi T; Zhao F; Baba R; Hirakawa T; Kuboki R; Suzuki K; Tomimatsu Y; O'Donnell P; Han S; Zach N; Nakashima M
    Skelet Muscle; 2023 Nov; 13(1):19. PubMed ID: 37980539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.
    Rebolledo DL; Kim MJ; Whitehead NP; Adams ME; Froehner SC
    Hum Mol Genet; 2016 Jan; 25(1):158-66. PubMed ID: 26604149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
    Wehling M; Spencer MJ; Tidball JG
    J Cell Biol; 2001 Oct; 155(1):123-31. PubMed ID: 11581289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB; Bostick B; Yue Y; Duan D
    Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydrobiopterin synthesis and metabolism is impaired in dystrophin-deficient mdx mice and humans.
    Lindsay A; Kemp B; Larson AA; Baumann CW; McCourt PM; Holm J; Karachunski P; Lowe DA; Ervasti JM
    Acta Physiol (Oxf); 2021 Apr; 231(4):e13627. PubMed ID: 33580591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.
    Timpani CA; Trewin AJ; Stojanovska V; Robinson A; Goodman CA; Nurgali K; Betik AC; Stepto N; Hayes A; McConell GK; Rybalka E
    Neurotherapeutics; 2017 Apr; 14(2):429-446. PubMed ID: 27921261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin.
    Nogami K; Maruyama Y; Elhussieny A; Sakai-Takemura F; Tanihata J; Kira JI; Miyagoe-Suzuki Y; Takeda S
    BMC Musculoskelet Disord; 2020 Jul; 21(1):479. PubMed ID: 32693782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase.
    Reilly SN; Liu X; Carnicer R; Recalde A; Muszkiewicz A; Jayaram R; Carena MC; Wijesurendra R; Stefanini M; Surdo NC; Lomas O; Ratnatunga C; Sayeed R; Krasopoulos G; Rajakumar T; Bueno-Orovio A; Verheule S; Fulga TA; Rodriguez B; Schotten U; Casadei B
    Sci Transl Med; 2016 May; 8(340):340ra74. PubMed ID: 27225184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.